PrEP for Women: Everything You Need to Know in 2026

Updated May 2026 · 8 min read

PrEP works for women — but the guidance is different than for men. Descovy, the most commonly prescribed oral PrEP, is not approved for people at risk through receptive vaginal sex. Only about 7% of eligible women in the US currently use PrEP. Here’s what you need to know about which medications work, how to get them free, and why PrEP matters for women.

Which PrEP Medications Are Approved for Women?

Important: Descovy is NOT approved for vaginal sex exposure

Descovy (emtricitabine/tenofovir alafenamide) was never tested in a clinical trial for people at risk through receptive vaginal sex. The FDA specifically excluded this population from Descovy’s PrEP approval. If you’re a cisgender woman at risk through vaginal sex, Descovy is not the right medication.

Approved PrEP options for cisgender women at risk through vaginal sex:

Generic Truvada (TDF/FTC)

Oral, daily pill. FDA-approved for all at-risk populations including receptive vaginal sex. Over 99% effective when taken daily. Generic versions cost $30–$100/month without insurance; $0 through telehealth or assistance programs. The most established PrEP option for women.

Apretude (cabotegravir)

Injectable, every 2 months. FDA-approved for all at-risk adults and adolescents, including women. Given as an injection at a clinic. Eliminates the need for a daily pill. Requires in-person visits every 2 months after initial loading doses.

Yeztugo (lenacapavir)

Injectable, every 6 months. FDA-approved June 2025 for all at-risk populations. A twice-yearly injection — the longest-acting PrEP option available. Clinical trials showed 99.9% effectiveness. Requires only 2 clinic visits per year after loading dose.

Descovy (TAF/FTC)

NOT approved for vaginal sex exposure. FDA-approved only for PrEP in people at risk through anal sex (cisgender men and transgender women). If your prescriber offers Descovy for PrEP through vaginal sex, ask about generic Truvada or injectable options instead.

Compare PrEP access options

Telehealth providers, local clinics, state programs, Medicaid, and manufacturer assistance can all be valid routes. Compare cost, lab method, medication options, location, privacy, and follow-up instead of defaulting to one provider.

Compare providers and programs →

Why So Few Women Use PrEP

Despite PrEP being approved for over a decade, only about 7% of eligible women in the US currently use it. Black and Hispanic/Latina women — the groups at highest risk for HIV — have the lowest PrEP uptake. Several factors contribute:

Awareness gap: PrEP marketing has overwhelmingly targeted men who have sex with men. Many women don’t know PrEP exists, don’t realize they’re at risk, or assume it’s only for men.

Provider barriers: Studies show that providers are less likely to discuss PrEP with women patients, even when risk factors are present. Women often need to advocate for themselves.

Descovy confusion: Since Descovy is the most widely advertised PrEP medication but isn’t approved for vaginal sex, some women are prescribed the wrong medication or are told PrEP “isn’t available” for them.

Stigma: PrEP is still associated with promiscuity in many communities. Women may face judgment from partners, family, or healthcare providers for seeking prevention.

PrEP During Pregnancy and Breastfeeding

The CDC and current perinatal guidelines recommend generic Truvada (TDF/FTC) as PrEP during pregnancy and breastfeeding when HIV prevention is needed. Studies show it is generally safe for both mother and baby. Injectable PrEP (Apretude) is also being studied during pregnancy, though data is more limited.

PrEP does not interact with hormonal birth control methods, including the pill, patch, ring, shot, implant, or IUD. You can use PrEP and birth control together safely.

How to Get Free PrEP as a Woman

Every pathway to free PrEP that exists for men also works for women. The options include telehealth (MISTR, Freddie), Gilead Advancing Access PAP for uninsured patients, Medicaid, community health centers, and state PrEP assistance programs. See our complete guide to free PrEP or use the eligibility tool to find your best option.

For injectable PrEP (Apretude or Yeztugo), you’ll need an in-person provider since injections can’t be administered via telehealth. See our injectable PrEP access guide for clinic options and cost coverage.

Frequently Asked Questions

Can women take Descovy for PrEP?

Descovy is FDA-approved for PrEP only in people at risk through anal sex. It was never tested in cisgender women at risk through vaginal sex. If your primary risk is through vaginal sex, generic Truvada (TDF/FTC) or injectable PrEP (Apretude or Yeztugo) are the approved options. Some providers do prescribe Descovy off-label for women, but this is not FDA-endorsed.

Does PrEP affect fertility?

There is no evidence that PrEP affects fertility in women. Studies have not shown any impact on the ability to become pregnant. PrEP can be safely used by women who are trying to conceive, are pregnant, or are breastfeeding.

Is injectable PrEP better for women?

Injectable PrEP may be a good fit for women who prefer not to take a daily pill, want a discreet option, or have difficulty with medication adherence. Yeztugo (every 6 months) is especially convenient. Both Apretude and Yeztugo are approved for all at-risk populations including women. The main trade-off is that injectable PrEP requires in-person clinic visits.

Should my partner know I’m on PrEP?

That’s entirely your decision. PrEP is a personal health choice, and you’re under no obligation to disclose it to anyone. Telehealth Some telehealth PrEP services ship medication in discreet packaging with no branding.